Cita APA

Gloyn, A., Diatloff-Zito, C., Edghill, E., Bellanné-Chantelot, C., Nivot, S., Coutant, R., . . . Robert, J. (2006). KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.

Citación estilo Chicago

Gloyn, A., C. Diatloff-Zito, E. Edghill, C. Bellanné-Chantelot, S. Nivot, R. Coutant, S. Ellard, A. Hattersley, and J. Robert. KCNJ11 Activating Mutations Are Associated with Developmental Delay, Epilepsy and Neonatal Diabetes Syndrome and Other Neurological Features. 2006.

Cita MLA

Gloyn, A., et al. KCNJ11 Activating Mutations Are Associated with Developmental Delay, Epilepsy and Neonatal Diabetes Syndrome and Other Neurological Features. 2006.